Spot Trading’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Spot Trading’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-60,700	Closed	-$215K	–	4205
2016 Q1	$215K	Buy	+60,700	New	+$313K	﹤0.01%	2163

Other funds holding ARLZ

PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Tiger Legatus Capital Management New York $62.4M AUM 24.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Spot Trading's ARLZ Position: Q2 2016 in Review

Spot Trading sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2016, closing a stake of 52,464 shares — an estimated $186K sold.

Spot Trading first reported a position in ARLZ in Q1 2016 and held it in 1 quarter. The position peaked at $186K in Q1 2016. 95 funds tracked by Wall St. Rank hold ARLZ as of Q2 2016.

Spot Trading reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2016 after selling out during the quarter.
Spot Trading sold 52,464 Aralez Pharmaceuticals Inc. shares in Q2 2016, an estimated $186K.
Spot Trading first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 1 quarter.
Spot Trading's Aralez Pharmaceuticals Inc. position peaked at $186K in Q1 2016.
95 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2016.

Based on Spot Trading's 13F filing for Q2 2016, filed 2 Aug 2016.